Leerink Partners Raised the Firm's PT on Intuitive Surgical (ISRG), Kept a Buy Rating

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Best Stocks to Invest in for High Returns. On July 23, Leerink Partners analyst Mike Kratky raised the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $587 to $593, while maintaining a Buy rating on the stock.

The analyst noted that the company delivered robust results in the fiscal second quarter of 2025. Both revenue and earnings per share exceeded expectations by 4% and 14%. Kratky noted that this was driven by strong revenue growth in all segments and a rise in da Vinci system placements in the United States.

Moreover, Intuitive Surgical, Inc. (NASDAQ:ISRG) also saw greater-than-expected global procedure growth and raised its full-year guidance for procedure growth and gross margin. It now expects international da Vinci procedure growth of approximately 15.5% to 17% in 2025, compared to 17% in 2024.

Intuitive Surgical, Inc. (NASDAQ:ISRG) is a medical technology company that develops robotic-assisted surgical systems, including the da Vinci surgical system and the Ion endoluminal system.

While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.